Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Endovascular grafts recalled due to risk of coating breaking off, entering bloodstream
Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer.
Healthcare advocacy in 2025: American Society of Echocardiography reviews a busy year
Healthcare policies have rapidly evolved in recent years, and 2025 was no exception. From payment policies to physician shortages, ASE and other medical societies had plenty to fight for throughout the year.
FDA finalizes Class I recall for Medtronic catheters
There is a risk that these catheters will fail to retain their shape during use, causing procedure delays and creating the risk of an adverse outcome. The FDA first warned users about the issue back in August.
FDA confirms new recall for Johnson & Johnson heart device over safety concerns
Three patient deaths have been linked to connectivity issues with these devices. The FDA has classified this as a Class I recall.
Integrating prior authorization into clinical workflows cuts costs, speeds up decisions
This utilization management tactic disproportionately affects specialties such as diagnostic radiology, radiation oncology and cardiology.

FDA grants breakthrough therapy designation to new drug candidate for FA cardiomyopathy

The new drug, LX2006, has already received the FDA's fast track designation. This latest distinction was based on early data from two separate clinical trials.

American Medical Association (AMA) Board of Trustees member Scott Ferguson, MD, FACR, a diagnostic radiologist in West Memphis, Arkansas, explains the combination of new healthcare policies under the Trump Administration are and problems that already existed under other administrations that were never fully addressed, are accelerating what the AMA sees as a growing crisis.

AMA trustee says the U.S. healthcare system is in a state of crisis

“We are in a crisis with healthcare research, administrative burdens, and with payment. Access for our patients is hurt," said American Medical Association (AMA) Board of Trustees member Scott Ferguson, MD, FACR.

Healthcare AI today: Nurses called to AI action, Big Beautiful Law, of mice and AI, more

If nurses fail to lead the way toward safe and responsible use of healthcare AI, the profession may lose its voice on emerging technologies.

Congress Money washington DC legislation coverage payment

With MPFS proposal on the way, electrophysiology groups outline their priorities

The Heart Rhythm Society and its new advocacy arm plan on pushing CMS to include certain policy improvements in the 2026 MPFS.

U.S. Department of Health and Human Services (HHS) sign.

HHS, RFK sued by medical associations over COVID policy shift

Multiple professional groups, including the American Academy of Pediatrics and the American College of Physicians, challenge recent policy changes to vaccine recommendations for COVID-19, which end routine inoculations for minors and pregnant women.

What’s in the ‘Big, Beautiful Bill’—and what was left out?

Sweeping tax cuts and reduced spending on Medicaid and SNAP were signed into law by President Donald Trump. However, a key provision that would have paused new AI regulations was removed by the Senate.

Farapulse Boston Scientific Pulsed Field Ablation PFA fda approval

FDA expands approval of Boston Scientific’s Farapulse PFA system

The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms.

President Trump finalizes spending bill with 2.5% rad pay bump, but no inflation-based Medicare reform

The bill also includes some $1 trillion in Medicaid cuts, with nearly 12 million kicked off insurance, drawing criticism from the American Medical Association and hospital lobbying groups.

Policy & Regulations

Endovascular grafts recalled due to risk of coating breaking off, entering bloodstream

Healthcare advocacy in 2025: American Society of Echocardiography reviews a busy year

FDA finalizes Class I recall for Medtronic catheters

FDA confirms new recall for Johnson & Johnson heart device over safety concerns

Integrating prior authorization into clinical workflows cuts costs, speeds up decisions